All News

New analysis shows the substitution would cut costs by $600 million in the United States annually.

American Heart Month is another example of the essential and valuable position that pharmacists hold in improving health care outcomes and optimizing patient-centered care.

Ronald T. Piervincenzi, CEO of US Pharmacopeia, discusses how drug shortages are related to medicine quality issues.

Study shows that 98% of cases of multi-system inflammatory syndrome in children (MIS-C) were unvaccinated, suggesting that vaccination reduces the chance of a child who had COVID-19 later developing MIS-C.

Genentech has released new 2-year data for individuals with diabetic macular edema and wet age-related macular degeneration.

The lingering effects of the COVID-19 pandemic, including supply concerns and staffing shortages, have made technological solutions become more crucial.

Ronald T. Piervincenzi, CEO of US Pharmacopeia (USP), discusses recent survey data demonstrating 90% of physicians had experienced an erosion of trust in the US supply chain’s ability to deliver safe, quality medicines.

Joint Complex supports joint function and lubrication, as well as tissue hydration.

Edoxaban (Savaysa) can reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation.

Sexual health is directly linked to mental health, Ramsden said, and both issues often go under-investigated in women.

Tiago Reis Marques, MD, PhD, CEO of Pasithea Therapeutics, addresses how pharmacists can respond to questions patients may ask them about ketamine and other psychedelic treatments.

Tiago Reis Marques, MD, PhD, CEO of Pasithea Therapeutics, explains how ketamine infusions work when administered in patients’ homes and what safety precautions would be taken by providers in this setting.

A variety of drugs from several medication classes are under investigation.

New composite pharmacy adherence measure is a major step in developing standard pharmacy performance measures focused on improving patient care.

Increasing physical activities and reducing caloric intake isn’t always enough to conquer obesity.

Many faculty members are adept at training and teaching pharmacists and pharmacy technicians how to perform physical exams and tests.

Taking appropriate doses of vitamins and minerals may aid in lowering the risk of cardiovascular disease.

Study shows that treatment with rituximab (Rituxan) for B-cell non-Hodgkin lymphoma prior to COVID-19 vaccination significantly lowered the number of patients who developed blocking antibodies for the virus.

Lack of immediate results, cultural barriers, and high costs lead many to gamble with their cardiovascular health, study results show.

An emerging focus is aligning targeted, safe, and effective therapies with patient goals.

Tralokinumab-ldrm is an interleukin-13 antagonist recently approved for the treatment of moderate-to-severe atopic dermatitis.

Ixazomib (Ninlaro, Takeda) has been found to improve survival in patients with multiple myeloma who have not undergone autologous stem cell transplant.

Sagely Naturals Pain Relief Cream combines CBD with powerful botanicals, peppermint, and menthol.

Diroximel fumarate (Vumerity) is indicated for the treatment of relapsing forms of multiple sclerosis.

Pharmacists are taking advantage of new opportunities, but there remain many other opportunities yet to be seized.

The calculation instrument displayed good discrimination, with a C-index of 0.72, as well as good calibration, investigators say.

Data suggest that omicron-specific CD8-positive T cell responses were more than 80% cross-reactive with the CD8-positive T cell response to the original strain of the virus.

New study results show that rapidly adding pounds in the first and final months of gestation likely plays a key role in the development of excess fat tissue in female children and adolescents.

Larotrectinib was the first drug to receive accelerated FDA approval for patients of all ages based on a common molecular marker, independent of tissue origin for targeted therapy.

Applying these findings in practice could improve clinicians’ ability to offer truly personalized cancer therapy by enabling consideration of toxicity along with other data predicting patients’ responses.